These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 28866278)

  • 1. Precise immune tolerance for hPSC derivatives in clinical application.
    Zhu W; Li M; Wu Y; Hu B
    Cell Immunol; 2018 Apr; 326():15-23. PubMed ID: 28866278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 'sweet' spot of cellular pluripotency: protein glycosylation in human pluripotent stem cells and its applications in regenerative medicine.
    Wang YC; Lin V; Loring JF; Peterson SE
    Expert Opin Biol Ther; 2015 May; 15(5):679-87. PubMed ID: 25736263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concise review: immunologic lessons from solid organ transplantation for stem cell-based therapies.
    Loewendorf A; Csete M
    Stem Cells Transl Med; 2013 Feb; 2(2):136-42. PubMed ID: 23349327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pluripotent stem cells and tolerance induction in organ transplantation.
    Imberti B; Monti M; Casiraghi F
    Curr Opin Organ Transplant; 2015 Feb; 20(1):86-93. PubMed ID: 25522138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of in vitro maintained and matured populations: potential barriers to engraftment of human pluripotent stem cell derivatives.
    Tang C; Weissman IL; Drukker M
    Methods Mol Biol; 2013; 1029():17-31. PubMed ID: 23756939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maturation of Pluripotent Stem Cell-Derived Cardiomyocytes: a Critical Step for Drug Development and Cell Therapy.
    Tan SH; Ye L
    J Cardiovasc Transl Res; 2018 Oct; 11(5):375-392. PubMed ID: 29557052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanized Mouse Models for Evaluation of PSC Immunogenicity.
    Hermsen J; Brown ME
    Curr Protoc Stem Cell Biol; 2020 Sep; 54(1):e113. PubMed ID: 32588980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced Therapeutic and Long-Term Dynamic Vascularization Effects of Human Pluripotent Stem Cell-Derived Endothelial Cells Encapsulated in a Nanomatrix Gel.
    Lee SJ; Sohn YD; Andukuri A; Kim S; Byun J; Han JW; Park IH; Jun HW; Yoon YS
    Circulation; 2017 Nov; 136(20):1939-1954. PubMed ID: 28972000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives.
    Liu X; Li W; Fu X; Xu Y
    Front Immunol; 2017; 8():645. PubMed ID: 28626459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunology of stem cells and cancer stem cells.
    Yang XF
    Cell Mol Immunol; 2007 Jun; 4(3):161-71. PubMed ID: 17601370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of immunologic tolerance for transplantation.
    Rossini AA; Greiner DL; Mordes JP
    Physiol Rev; 1999 Jan; 79(1):99-141. PubMed ID: 9922369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory immune cells and functions in autoimmunity and transplantation immunology.
    Papp G; Boros P; Nakken B; Szodoray P; Zeher M
    Autoimmun Rev; 2017 May; 16(5):435-444. PubMed ID: 28286106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of human embryonic stem cells: can we achieve tolerance?
    Drukker M
    Springer Semin Immunopathol; 2004 Nov; 26(1-2):201-13. PubMed ID: 15549307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Technical approaches to induce selective cell death of pluripotent stem cells.
    Jeong HC; Cho SJ; Lee MO; Cha HJ
    Cell Mol Life Sci; 2017 Jul; 74(14):2601-2611. PubMed ID: 28246701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies for future histocompatible stem cell therapy.
    Nehlin JO; Barington T
    Biogerontology; 2009 Aug; 10(4):339-76. PubMed ID: 19219637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem Cell Therapies in Clinical Trials: Progress and Challenges.
    Trounson A; McDonald C
    Cell Stem Cell; 2015 Jul; 17(1):11-22. PubMed ID: 26140604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome editing in pluripotent stem cells: research and therapeutic applications.
    Deleidi M; Yu C
    Biochem Biophys Res Commun; 2016 May; 473(3):665-74. PubMed ID: 26930470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.